NOTE! This site uses cookies

By continuing to browse the site you are agreeing to our use of cookies. For more detalis, see Read more

Accept

What are you looking for?


Johnson & Johnson delays distribution of Covid-19 vaccine to Europe

Deliveries of the Janssen jab were expected this week but have been paused after as United States investigates reports of rare blood clots

SHARE

13 April 2021 04:44 PM

by

ACN | Barcelona

Johnson & Johnson has announced that it is delaying the distribution of the Janssen vaccine to Europe "proactively" while studying the cases of rare blood clots in the United States. 

The EU was due to start administering the Janssen vaccine this week. Spanish health minister, Carolina Darias, said earlier in the week they would be used for those aged between 70 and 79

Earlier on Tuesday, the health agency of the US, known as the FDA, recommended suspending the use of the jab after six “severe” cases of rare thrombosis were detected. 

The European Medicines Agency (EMA) said that it is investigating the side effects and will announce the results of their analysis once a conclusion is reached. 

For now, the EMA say it is “not clear” that a link exists and has not deemed it necessary to discourage its use while they investigate the cases. 

“EMA’s scientific opinions provide member states with the information they need to make decisions about vaccine use,” an EMA spokesman stated.

 

SHARE

  • A woman walks with a bicycle outside a Janssen branch in the Netherlands (by REUTERS / Piroschka van de Wouw)

  • A woman walks with a bicycle outside a Janssen branch in the Netherlands (by REUTERS / Piroschka van de Wouw)

RELATED